The site will go back to normal as quickly as possible for access as quickly as possible. We appreciate your patience with this brief lapse of downtime.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Utada Hikaru
Dr. Hamer firmly believes that if the conflict is resolved, the cancerous or necrotic process is reversed to repair the damage and return the individual to health. This would also support the belief, observations and experiences of those such as Louise Hay, (who claims to have healed herself from cancer and assisted many others in doing the same), Bernie S Siegel MD (author of Love, Medicine Miracles), and Leon Jay (an Auckland based Emotional Release Therapist).
Leon, who sees this pattern in many of his clients, says that while we are unable to say for sure that emotional release of past traumas will prevent cancer from returning, I believe it to be one of the most important components to any cancer treatment. Each client is very different, yet the similarities in nature between the emotional trauma and the cancer type cannot be ignored.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Kumi Koda
Peter Schmid, MD, and colleagues from Imperial College London in the United Kingsom, describe the treatment and outcomes for 62 patients with this rare tumor; they collected these patients from throughout the United Kingdom over the past 30 years. This represents "the world's largest series," according to a Lancet press release highlighting the report.
"In view of the extreme rarity of placental-site trophoblastic tumors, substantially increased datasets are unlikely to be obtained in the near future," Dr. Schmid and colleagues comment.
Unclear Why Some Cells Become Cancerous
PSTTs are slow-growing malignant tumors that present months or even years after a normal pregnancy, abortion, miscarriage, or abnormal pregnancy, such as hydatidiform moles. The researchers note that PSTT was diagnosed in 1 in 20,000 women in the United Kingdom between 2003 and 2007.
Trophoblasts are formed during the first stage of pregnancy. They are the first cells to differentiate from the fertilized egg, supplying nutrients to the embryo and then developing into a large part of the placenta. "Exactly why some of these cells in some pregnancies should acquire changes that make them become a cancer is unclear," senior author Michael Seckl, PhD, FRCP, told Medscape Oncology .
PSTT can occur after any type of pregnancy, but it occurs most commonly after a normal pregnancy, Dr. Seckl continued. "Presumably, some placental cells are left behind. . . . We know this can happen in normal pregnancy and while in most cases these cells die off, in some they persist and can eventually turn into this type of cancer."
Rarest Form of Disease, and Biologically Different
PSTT is the rarest form of gestational trophoblastic disease, accounting for only 0.2% of the total of these disorders, and it is biologically different from the other forms, the researchers explain.
In an accompanying editorial, Ernest Kohorn, MD, from the Department of Gynecology at Yale University in New Haven, Connecticut, explains that in other forms of trophoblastic neoplasia, human chorionic gonadotrophin (hCG) is a reliable marker of the persistence of trophoblast cells, and the concentration of hCG correlates precisely with the tumor load. "Single-agent chemotherapy cures 99.9% of such patients, provided that the treating physician is familiar with the management of gestational trophoblastic disease and the patient is compliant," he writes.
However, PSTT is different in that the tumor load is not accurately correlated with the concentration of hCG, Dr. Kohorn notes. It also appears to be less sensitive to chemotherapy, he adds. Unlike other forms of gestational trophoblastic disease, which tend to occur after an abnormal pregnancy, PSTT can follow any type of pregnancy event, and "not infrequently" becomes clinically apparent even years later. In addition, there is great variability in its malignant aggressiveness, he writes.
Commenting on the paper, the editorialist writes: ""What Schmid and colleagues show more convincingly than was previously evident is that the greater the interval between the index pregnancy and the appearance of overt neoplasia, the more likely the disease will be aggressive."
Patients Treated With Surgery, Chemo, or Both
Dr. Schmid and colleagues report on the outcomes of 62 women with PSTT, who were diagnosed from among a series of 35,550 women registered with gestational trophoblastic disease in the United Kingdom between 1976 and 2006.
More than half of these patients (39 of 62; 63%) had locoregional disease, and the remaining 23 (37%) had distant metastases, the majority in the lung, but also at various other sites. Six patients had distant metastases at 2 or more sites. Nearly all of them (59 patients; 95%) had raised concentrations of hCG, but in most of them (41 patients; 69%), the levels were only moderately increased.
Most of the patients (53 patients; 85%) had surgery, either as initial treatment or after chemotherapy. All of the women had an abdominal hysterectomy, and some also had their ovaries removed or lymph nodes sampled.
Most of them (42 patients; 68%) also received chemotherapy, either as initial treatment or after surgery. This comprised various combinations of drugs, including dactinomycin, etoposide, methotrexate, folinic acid, vincristine, cyclophosphamide, and/or cisplatin.
Median follow-up was 6.3 years (range, 2.3 to 10 years). Overall, 14 patients (23%) died. From these figures, the researchers calculated a probability of overall survival of 73% at 5 years and 70% at 10 years.
When they applied univariate analyses to these data, the researchers found that the only significant association that predicted overall survival was time from antecedent pregnancy. There appeared to be a cutoff of 48 months from the antecedent pregnancy that could differentiate between a patients' probability of overall survival and death. Of the 14 patients who died, 13 patients had experienced the antecedent pregnancy more than 4 years previously, and only 1 patient had experienced it more recently (hazard ratio, 93.
Similar posts: breast cancer metastasis
- Mood:More emotions
- Music:Southern All Stars
Breast feeding power prohibit breast cancer to a lengthy extent. Folic acid is spoken to indemnify the risk of breast cancer. Absolute has been start that female who consume 3 - 4 glasses of alcohol everyday hold increased prone to breast cancer.
However, if they consume sufficient amount of folic sharp, ergo they have lower risks of the disease. Foods flush in folic tart encompass citrus juices and fruits, peas, dried greenback and puerile young vegetables consistent spinach. In disposal to discourage breast cancer, avoid being a second hand smoker.
Receipt your ovaries removes not alone reduces the chances of breast cancer by at lead off 60 % but solid besides reduces the risk of ovarian cancer by thanks to much since 96 %.
Screening:
The informal methods of breast cancer screening are clinical and self breast examinations, caress - stream mammography, genetic testing and MRI. In the progression of self - examination, you must to examine your own breasts in sequence to detect lumps in the breast tissues. Mammography examines the breast for helping strange lumps or proletariat.
Regular mammography is recommended for prevention of breast cancer, especially for altitudinous - risk humans and older masculinity. MRIs burden further exhibit used for spotting possible cancerous cats.
Treatment:
The main treatment procedure for breast cancer is surgery in which the tumor is localized. Other methods are aromatase inhibitor, tamxifen, radiotherapy and chemotherapy. Depending on the age, size, metastasis and type of cancer of the patient, they are roughly categorized into low risk and hovering risk tribe and all of them obtain mismated treatment procedures. Other possibilities may insert chemotherapy, unaffected therapy and hormone therapy.
ILT or Interstitial laser thermotherapy is an hep road of treating this disease. Radiation treatment may besides emblematize used for destroying cancerous cells which may linger precise next surgery.
Similar posts: breast cancer metastasis
- Mood:Good
- Music:Kumi Koda
Similar posts: breast cancer metastasis
- Mood:Good
- Music:Heartbreak Hotel
Life Extension Vitamins Life Extension Super CLA + Guarana 120 Sgels 1000mg - Free Shipping In a study presented at the Experimental Biology 2002 meeting, CLA alone was shown to cause a substantial decrease in fat mass, and for those who received CLA plus guarana, both adipocyte (fat cell) size and number were decreased by 50%. As an added benefit, sesame lignans have been shown to further increase the burning of fat by stimulating fatty acid oxidation in the liver. As with any fatty acid, CLA can be oxidized by free radicals once it has been ingested. Sesame lignans help prevent the oxidation of CLA, providing health benefits without negative impact. CLA Increases Lean Tissue Builds muscle mass Enhances energy levels Reduces body fat May help Type II diabetes Protects against athersclerosis Reduces protein degradation from aging Contains anti-cancer properties CLA is able to decrease fat storage and maintain lean muscle tissue. Most diets fail because when fewer calories are consumed, the metabolic rate slows down, restricting the amount of weight one can lose. In contrast, CLA reduces body fat by INCREASING basal metabolic rates, enabling DIETERS TO EAT MORE FOOD AND STILL LOSE WEIGHT AND INCREASE MUSCLE MASS. CLA MAY PROTECT AGAINST CANCER WHILE BUILDING MUSCLE. Studies show it may help protect against many diseases including atherosclerosis and cancer. CLA is a potent cancer preventative agent in animal studies (Journal of Nutrition, Dec. 1999). EXPERIMENTAL CELL RESEARCH, JULY, 99 - CLA was shown to prevent mammary cancer. When ingested during the active phase of cancer development, rats were protected from further development of breast cancer. CLA was shown (CARCINOGENESIS) to reduce the size of breast tissue in rats, reducing the incidence of carcinogenesis. It was shown that CLA inhibits the growth of prostate cancer. It can prevent and inhibit certain cancers. CLA has the ability to suppress arachidonic acid.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Mai Kuraki
Nevertheless, cancer remains a leading cause of death, coming second after cardiovascular disease in 2006. The numbers are still huge a total of 1,479,350 new cancer cases and 562,340 cancer-related deaths are projected in 2009.
The annual cancer-statistics report from the ACS was published online May 27 in CA: A Cancer Journal for Clinicians.
"A drop of 1% or 2% per year in the cancer mortality rate may sound small, but as this report shows, that adds up to 650,000 cancer deaths avoided over 15 years," said John R. Seffrin, PhD, chief executive officer of the ACS, in a statement. "And because the rate continues to drop, it means that in recent years about 100,000 people each year who would have died if cancer death rates had not declined are living to celebrate another birthday. That is undeniable evidence of the lifesaving progress that we, as a country, must dedicate ourselves to continuing."
Declines Seen in Both Mortality and Incidence
Since 1975, there have been notable improvements in relative 5-year survival rates for many types of cancers and for all cancers combined. These increased rates reflect a combination of earlier diagnoses and advances in treatment. But the report points out that little progress has been made in improving outcomes for several different types of malignancies, including those of the lung and pancreas. In addition, cancer incidence and mortality can vary by sex, race/ethnicity, education, and geographic area.
Between 1990 and 2005, the overall cancer death rate decreased by 19.2% in men and by 11.4% in women. In men, the decline in morality rates was largely due to decreasing rates of lung (37%), prostate (24%), and colorectal (17%) cancers, which accounted for almost 80% of the total decrease. In women, the decreased mortality rate was largely driven by declining rates in breast (37%) and colorectal (24%) cancers, which accounted for 60% of the total decrease.
Cancer incidence rates decreased by 1.8% per year in men from 2001 to 2005, and by 0.6% per year in women from 1998 to 2005. These rates were due largely to decreases in the 3 major cancer sites in men (lung, prostate, and colorectum) and the 2 major sites in women (breast and colorectum).
Trends in Incidence and Outcomes
In 2009, cancers of the prostate, lung and bronchus, and colon and rectum will account for about 50% of all newly diagnosed cancers in men, with prostate cancer alone accounting for 25% (192,280) of incident cases. Based on data from 1996 and 2004, an estimated 91% of new cases of prostate cancer are expected to be diagnosed at local or regional stages; the good news is that 5-year relative survival for these cases approaches 100%.
Among women in 2009, the 3 most commonly diagnosed types of cancer will be cancers of the breast, lung and bronchus, and colon and rectum, accounting for 51% of estimated cancer cases. Breast cancer alone is expected to account for 27% (192,370) of all new cancer cases.
Cancers of the lung and bronchus, prostate, and colorectum in men, and cancers of the lung and bronchus, breast, and colorectum in women continue to be the most common fatal cancers, the report points out, and these 4 malignancies account for nearly half of all cancer-related mortality among people of both sexes.
However, mortality rates are declining for these 4 cancer sites, except for lung cancer in women, in which rates stabilized from 2003 to 2005. The incidence trends for these major cancers have also declined, except for lung cancer in women, in which rates are still increasing, but are doing so more slowly than in previous years.
Influence of Race/Ethnicity
Both incidence and mortality continue to vary considerably among racial and ethnic groups. Compared with white men, black men have an 18% higher incidence rate and a 36% higher death rate for all cancer sites combined. Conversely, black women have an incidence rate that is 6% lower than the rate for white women, but their mortality rate is 17% higher.
Cancer incidence and death rates are generally lower in other racial and ethnic groups than they are in whites and blacks, although both incidence and death rates tend to be higher for cancers of the uterine cervix, stomach, and liver than in whites.
Once the diagnosis of cancer is made, black Americans have worse outcomes than whites. The 5-year relative survival rate is lower in every stratum of disease stage and for nearly every cancer site. Disparities in outcomes are multifactorial, and include factors such as unequal access to quality healthcare and/or differences in comorbidities.
Increase in Cancer Deaths in 2006
Cancer accounted for about 23% of all deaths in the United States in 2006, but there were 568 more cancer deaths reported that year than in 2005. This is believed to be due to the growth and aging of the population, because "the decrease in the age-standardized death rates did not offset the influence of the aging and growth of the population on the total number of cancer deaths," the report notes.
However, when the mortality causes are ranked by age groups (in 20-year intervals), cancer is 1 of the 5 leading causes of death in all age groups and in both sexes. It is the leading cause of death for women between 40 and 79 years and for men between 60 and 79 years, and surpasses heart disease as the leading cause of death for men and women younger than 85 years.
Lifetime Probability of Developing Cancer
The authors of the report emphasize that these estimates are "based on the average experience of the general population and may overestimate or underestimate individual risk because of differences in exposure and/or genetic susceptibility." But based on population data, the lifetime probability of being diagnosed with an invasive cancer is 44% for men and 37% for women. Because of the earlier median age of diagnosis for breast cancer, compared with other major malignancies, women appear to have a slightly higher probability of being diagnosed with cancer before the age of 60 years.
"Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age," write the authors. "Further progress can be accelerated by applying existing cancer-control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment."
The researchers have disclosed no relevant financial relationships.
CA Cancer J Clin. Published online before print May 27, 2009.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Sukiyaki
Similar posts: breast cancer metastasis
- Mood:More emotions
- Music:Southern All Stars
A reflective and ultimately optimistic memoir. Midwest Book Review Beautiful, moving, informative, uplifting. I only wish there had been a book like this back when I had cancer. Lee Christopher, author of Jaded Love A terrific read well-written, frank, and honest. This books many hard-won truths make it truly special and inspiring. Nina Romberg, author of Shadow Walkers Leonore H. Dvorkin was born in 1946 in Chicago, Illinois. She has lived in nine different states and Germany. Her two BA degrees in languages are from Indiana University (Bloomington) and Metropolitan State College of Denver. She and her author husband, David Dvorkin, have lived in Denver, Colorado since 1971. Their son, Daniel Dvorkin, has written two novels with his father. Leonore works as a tutor of Spanish and German, a translator, a proofreader, and a weight training instructor. In 1977, she won the YWCA Sportswomen of Colorado Award in the category of Health and Physical Fitness. Her publishing credits include numerous articles on fitness and nutrition, the literary novel Apart From You (Wildside Press, 2000), and the autobiographical book Why Im Glad I Had Breast Cancer (Wildside Press, 2005). www.dvorkin.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Mai Kuraki
For many cancer patients undergoing mastectomies, reconstructive breast surgery can seem like a first step to reclaiming their bodies. Last month I wrote a piece on reconstructive breast surgery and specifically the lack of options presented to women by their surgeons. This piece was prompted by an article which appeared last December in the New York Times stating that “Even as promising new operations are gaining traction at academic medical centers, plastic surgeons often fail to tell patients about them.” The article reports that ” only one third of women undergoing operations for breast cancer said their general surgeons had discussed reconstruction at all, according to a study published in the journal Cancer.
I was struck by a piece in the article which said that patients should not necessarily accept the first thing they hear as the end-all, because that is not necessarily the full story and once again highlights for me the importance of patient empowerment. Although women “don’t choose their diagnosis, they can choose to go ahead with reconstruction or not, and with the aid of a knowledgeable plastic surgeon they can choose what their options might be…Then they have that much more power over their lives if they have that power to choose.”
This week I read an article reported in Medical News Today, which states that many women in the US who undergo mastectomy surgery which will result in disfiguring scars because they are unaware of the availability of Skin-Sparing Mastectomies and did not ask their surgeons about this treatment option.
A Skin-Sparing Mastectomy is a surgical technique to remove cancerous breast tissue by using the same minimal and judiciously placed incisions used by plastic surgeons for elective breast surgery.
Despite the availability of skin-sparing mastectomies, a recent California study published in The American Surgeon found that more than one-third of board-certified breast surgeons surveyed still regularly use the archaic practice of cutting across the whole breast, resulting in unnecessarily disfiguring scars even after breast reconstruction.
Amidst the shock and anxiety of a breast cancer diagnosis, many women and some physicians consider the appearance of the breasts of secondary importance and not worthy of serious consideration compared to the treatment of cancer, said Joel Aronowitz, M.D., Clinical Chief of Plastic Surgery at Cedars Sinai Medical Center and founder of the Breast Preservation Foundation, a non-profit organization dedicated to increasing awareness and educating women and their caregivers about skin-sparing mastectomy.
We know that skin sparing and old style transverse mastectomy techniques are equal in effectiveness as cancer treatments. Therefore, every woman has a right to be informed about choices in mastectomy surgery that improve the cosmetic appearance of the breast and be able to consider all options before embarking on major surgery that will impact their overall quality of life.
The skin-sparing technique uses a simple, small, circular incision around the edge of the nipple area. The surgeon leaves all or most of the overlying breast skin, preserving the natural skin envelope that can be filled with an implant or with a patients own fat tissue from another part of the body. This skin-sparing technique is appropriate for women whose breast cancer does not invade the skin of the breast and particularly when immediate reconstruction is planned.
Today, effective mastectomy can be performed with far better cosmetic results. Since new breast cancer cases are among the highest rates ever recorded and breast cancer survival rates are also on the rise it is necessary for patients and their physicians to consider what treatment options will positively affect the patients overall health, healing and quality of life, post cancer.
I want to make sure that the information I put forward in this blog is accurate and relevant to the Irish context, as part of my frustration when I was diagnosed with breast cancer was what I found to be a lack of information relevant to Irish women. Since then, I have become much better informed and now through my connections in the breast cancer charity field have a team of breast cancer experts to call on. So I brought this article to the attention of an Irish breast surgeon to establish its relevance to the Irish woman, considering reconstructive surgery. She confirmed that Skin Sparing Mastectomy (SSM) has been around since the 90s and in carefully selected patients is a perfectly good option. What is critically important is that whoever is doing it is trained to do so and it is performed in a properly selected breast cancer population. It is growing in popularity as we have more and more data to suggest it doesnt affect the outcome of affected women. Hence the importance of someone trained to do it . That population is officially women with Stage 1 or 2 cancer, however, the boundaries of this are being pushed out so maybe we will see that change with time. She also points out that there is some controversy as to the role of SSM with women with hereditary breast cancer as we know that any amount of residual cancer tissue left has the propensity for breast cancer develop.
I hope this post has been of benefit to any woman considering her options when it comes to breast reconstruction. It is important to inform ourselves of all our options, as we may not always be offered them by our medical team.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Chage and Aska
Similar posts: breast cancer metastasis
- Mood:Cry
- Music:Namie Amuro
My dog, Dixie Chick
As he subdued a small dog he explained to the owner that she had to live in the now; she couldnt think about what the dog did in the past or she would continue to expect a bad outcome which would ensure bad behavior from the dog. This is the best advice in the world! I have heard it before and often, but it never hit me until the dog whisperer demonstrated it with the dog. I think that when you are a breast cancer survivor learning to expect the best from every day is how we need to live. Accepting that you are well today and not expecting cancer to come back is to really live. Living in the now is the best way to prepare for the future. Often as survivors we really do hold our breath and wait for the bad outcome in between living. I guess living in the now means no waiting, no holding our breaths and definitely no expectation of another cancer diagnosis.
My greatest flaw is impatience and wanting to know whats coming. It often steals what I do know. I am working on it though. I think hearing it from the dog whisperer helped me understand how to do it. I wont be asking Dixie Chick for help though, she is more impatient than me and I really think she has no plans to behave.
Similar posts: breast cancer metastasis
- Mood:Cry
- Music:Chage and Aska
Similar posts: breast cancer metastasis
- Mood:Good
- Music:Utada Hikaru
Alpens 825 263P Binocular is one of two Alpen Binoculars that are offered in association with the National Breast Cancer Foundation . Pink is the color most associated with breast cancer research. More than 40,000 Americans die each year of breast cancer and (400,000 worldwide)! The Alpen 263P 825 Binocular has a 25mm objective lense and much more. Alpen Optics created its Pink Binocular series to help generate awareness and show theyre support for this cause and to help find a cure. Specifications for the Alpen National Breast Cancer Foundation 825 263P Binocular: Item Number: 263P Description: 825 Wide Angle Magnification: 8x Objective Lens Diameter: 25mm Focus System: Center Prism Type: Porro F.O.V. (ft @ 1000 yds): 430 Exit Pupil: 3.1mm Eye Relief: 12mm Lens Coating: Multi-coated Net Weight (oz.): 11 Type of Neckstrap: Standard Tripod Adaptable: No Close Focus: 14 Feet Prism Material: BAK4 Waterproof / Fogproof: No Type of Case: Nylon Features of the Alpen 825 263P National Breast Cancer Foundation Binocular: Alpen PINK 263P Features: Lightweight, compact construction Wide angle field of view (430 ft.
Similar posts: breast cancer metastasis
- Mood:Good
- Music:Ami Suzuki
University of Utah researchers have found that delayed-enhancement magnetic resonance imaging (DE-MRI) holds promise for predicting treatment outcomes and measuring disease progression for patients with atrial fibrillation (AF), a little known heart rhythm disorder that affects more than 3.5 million Americans and causes more than 66,000 deaths a year.
Similar posts: breast cancer metastasis
- Mood:Very good
- Music:Southern All Stars
The new study looked at a screening regimen that combines ultrasound and a blood test for CA-125, a marker for women's cancer.
Similar posts: breast cancer metastasis
- Mood:More emotions
- Music:Chage and Aska
The treatment of uterine cancer is performed on the basis of grade and stage of the cancer. Abdominal hysterectomy is a standard therapy, which involves prerogative the surgical removal of the woman ' s uterus along with both the ovaries and fallopian tubes, washing of the abdominal cavity to finish malignant cells and the selective removal of the aortic and pelvic lymph nodes. Bountiful doctors elevate usage of hormone therapy that removes the alternative of metastatic cancer. Besides, masculinity again nail down for radiation therapy for the treatment of their uterine cancer.
Although treatment is a alternative for Uterine Cancer, still you should gate immediate occupation coming gaze the symptoms. Don ' t rent undoubted extent a rolled from locality essential cannot appear as cured!
To Your Health.
Similar posts: breast cancer metastasis
- Mood:Cry
- Music:Kumi Koda
Cancer Advocates, Survivors Address The Now What? Stage Of Cancer
This report from Medical News Today relates to cancer survivorship in the US, but the concerns are of relevance to those of us who are navigating the now what stage of our cancer journey here in Ireland too.
Survivorship is the new buzz word in cancer care as advances in the treatment and detection of cancer have resulted in an estimated 12 million cancer survivors in the United States alone. However, cancer survivors need assistance navigating the complex issues they face after treatment. ABC News veteran Sam Donaldson echoed this fact and raised a host of survivorship issues while moderating a roundtable held at the National Comprehensive Cancer Networks 14th Annual Conference on March 12.
A cancer survivor, Ellen Stovall of the National Coalition for Cancer Survivorship explained, is a term used to describe anyone who has been diagnosed with cancer as well as caregivers and loved ones of those diagnosed with the disease. The term survivorship was first coined in 1985, but was expanded to include family members and caregivers since no one can survive cancer alone.
Panelist and cancer advocate Elizabeth Edwards noted the importance of a strong support system because as a cancer survivor, the most benign things will scare you to death. She relayed a story about how she recently thought a rough spot on her neck may have been a skin cancer metastasis, when it was only a curling iron burn.
Mary McCabe, RN, BS, MA, from Memorial Sloan-Kettering Cancer Center touched on the fear factor that cancer survivors continue to live with explaining that her patients often energize themselves to get through the initial treatment, but then they can run out of gas for the s next period that comes after treatment.
The panelists noted that with a documented shortage of oncologists, survivors are challenging the capacity of our healthcare system when they become reluctant to leave their oncologist at the conclusion of treatment. Furthermore, the lack of clear evidence for what constitutes best practices in caring for patients with a history of cancer contributes to a wide variation in care.
Incorporating cancer into a persons whole life, is something that has not traditionally been appreciated by clinicians in their clinical practice, said Ellen Stovall, National Coalition for Cancer Survivorship.
Acknowledging this concern, Douglas Blayney, MD, of the University of Michigan Comprehensive Cancer Center, noted the importance of transition care plans for survivors. As oncologists, were usually focused on recurrence, surveillance, and a secondary cancer developing. However, the transition visit is imperative and needs to be a defined episode to recognize the psychosocial issues attributed to cancer survivorship.
Author and New York Times columnist Jane Brody applauded Dr. Blayneys approach stating that, Clinicians need to initiate the conversation of psychosocial issues that may arise after treatment at the time of diagnosis and that patients should not be responsible for reinventing the wheel in terms of receiving referrals to survivorship resources.
Catherine Alfano, PhD, National Cancer Institute Office of Cancer Survivorship, stressed incorporating the results of a recent Institute of Medicine report on cancer care that identified the need for a screening system that would address the myriad of physical and emotional issues cancer survivors face after treatment. She noted that this would benefit the clinician as well as the patient as they could easily determine what the patients top concerns were and refer them to appropriate care.
Kenneth Miller, MD, of the Dana Farber Cancer Institute, also encouraged the development of a standard check list of-sorts that clinicians could utilize to ensure survivorship would become a part of their treatment plan for each patient.
The need for consistent and clear communication between healthcare providers and cancer survivors was a topic everyone on the panel felt was lacking and needed improvement.
Ellen Stovall felt that patients often arent given enough credit for what they can understand. Elizabeth Edwards mentioned that she felt that her clinicians were honest, but vague where they thought they needed to be because perhaps the assumption was that she couldnt emotionally handle the prognosis. Jane Brody also noted that shes surprised at how many clinical questions her readers ask her instead of their clinicians.
Dr. Blayney acknowledged the communication gap and stressed again the importance of open communication on past, present, and future issues that arise with cancer survivors.
In conclusion, Mr. Donaldson praised the current administration for earmarking funds for cancer research. Dr. Alfano affirmed the NCIs commitment to work with the new administration and obtain additional funding dedicated to the entire spectrum of cancer care including survivorship.
Similar posts: breast cancer metastasis
- Mood:More emotions
- Music:Utada Hikaru
Answer: Stomach cancer, as we have seen, is often diagnosed late. A good evaluation before starting treatment is important, since it can dramatically change therapy, as we will see.
Following tests are recommended:
CT scan
PET-CT, if available
EUS in few early cases
Laparoscopy
Out of above tests, most important tests in our scenario are a good quality CT scan, and laparoscopy. Both are widely available.
CT scan mainly helps to detect extent of local disease (along with endoscopy findings), lymphadenopathy-perigastric and distant, liver metastases. In one study, accuracy of PET-CT in preoperative staging was 68%, compared with 53% for CT scan alone. Newer MDCT scans, such as 64 slice CT scanners are likely to be better, however. Fortunately, PET-CT is now more widely available in India, including in Gujarat.
In one study, 657 patients with potentially resectable stomach cancer underwent laparoscopy before surgery. 31% of these patients were found to have metastatic disease. Thus laparoscopic staging helped to avoid a major surgery and related morbidity in these patients. Also, it allowed earlier initiation of palliative therapy.
Thus, at least a routine good CT scan and laparoscopy would help to avoid many open and close surgeries and palliative resections, and use patients limited resources for right treatment.
Que: What is your next step?
Ans: Now that we have completed staging the patient, patient will have either resectable OR non resectable tumor.
Non resectability could be secondary to distant spread/metastatic disease (which includes peritoneal spread) OR locally advanced disease.
Similar posts: breast cancer metastasis
- Mood:Good
- Music:Sukiyaki
As you can see this type of tumor is actually one of the worst forms of breast cancer although it sounds worse than it is. So no need to worry women if your breasts feel a little warm, thats normal. There will never be any form of ignition or fire from your breast. Thats just the name they give it because of the redness that occurs The good news is that inflammatory breast cancer only occurs in 1 - 7 percent of all patients. So like I said this is a rare form of cancer but what I want to do is help those who do suffer from it. I feel sorry for all cancer patients, I wish I could buy you all gifts, so Ill give you the information you need to be healthy.
We know that not many people have cancer because it is rare but the one thing that most studies have found is that unlike other forms of cancer inflammatory breast cancer normally occurs in younger women instead of older women. The more common, form of breast cancer starts to show in women over 35, not so with inflammatory breast cancer this basically means tons of young women will be dying before their times, so if you can ever participate in any event please do so, every little bit helps. Another oddity about this form of cancer is its ability to form cancer cells in older men. His has not been studied much but it has shown to be true for the most part.
Lastly there have been signs that you might be effected by your family genealogy. So if you have a female relative who has had inflammatory breast cancer I highly recommend that you continue reading this blog and and consult a physician asap as you could be effected. Until doctors are able to find more about this form hindrance you are basically left to defend yourself.Please take all the steps that you can to prevent anything from happening to you.
Everyday, dont be a victim. Dont let your life go. In order to stay strong you must take steps, well get into that more next week.
Learn the untold secrets that most doctors know about inflammatory breast cancer but dont tell you.
Similar posts: breast cancer metastasis
- Mood:Cry
- Music:Mai Kuraki
Profile
![[info]](http://l-stat.livejournal.com/img/userinfo.gif)
beautyandsport- beautyandsport
Syndicate
